Collagen-Based Template for Treatment /Cerebral Aneurysm

Information

  • Research Project
  • 6621861
  • ApplicationId
    6621861
  • Core Project Number
    R43HL069217
  • Full Project Number
    5R43HL069217-02
  • Serial Number
    69217
  • FOA Number
    PAR-01-006
  • Sub Project Id
  • Project Start Date
    4/1/2002 - 22 years ago
  • Project End Date
    3/31/2007 - 17 years ago
  • Program Officer Name
    LUNDBERG, MARTHA
  • Budget Start Date
    4/1/2003 - 21 years ago
  • Budget End Date
    3/31/2007 - 17 years ago
  • Fiscal Year
    2003
  • Support Year
    2
  • Suffix
  • Award Notice Date
    -
Organizations

Collagen-Based Template for Treatment /Cerebral Aneurysm

The overall goal of this research proposal is to design, engineer, and test in vivo a type I collagen-based endovascular template for the therapy of cerebral aneurysms. Cerebral aneurysms are present in at least 0.5-1.0% of the United States population, and aneurysm rupture remains an important cause of morbidity and mortality. Even in major referral centers, a significant number of aneurysms are not amenable to surgical repair. The device described in this proposal is specifically designed to act as a vascular template to support and guide vascular regeneration at the base of the aneurysm and to inhibit blood flow into the aneurysm sac, resulting in thrombosis of the aneurysm. A preliminary in vitro study was performed using the initial prototype developed by the principle investigator of this proposal. The results demonstrated that type I collagen may be used to construct a hemocompatible tubular template that produces a modest reduction in arterial luminal dimension and little change in flow. During phase I, we will examine the in vivo feasibility of the collagen template in a rabbit model, while in phase II we will extend the period of study in the rabbit model to evaluate the long term effects of the collagen template. The neurosurgical and interventional neuroradiology community is in serious need of a viable therapy for wide-neck aneurysms. If an acceptable template is developed, it is estimated that the yearly gross revenues from such a template would exceed at least $100 million. Furthermore, the work described in this proposal could be expanded to apply to a wide range of clinical applications, including percutaneous angioplasty, closure of arteriovenous fistulae, and billary, renal and esophageal procedures. If widely applied clinically, a collagen-based template could generate well over $1 billion per year worldwide. PROPOSED COMMERCIAL APPLICATIONS: See above abstract

IC Name
NATIONAL HEART, LUNG, AND BLOOD INSTITUTE
  • Activity
    R43
  • Administering IC
    HL
  • Application Type
    5
  • Direct Cost Amount
  • Indirect Cost Amount
  • Total Cost
    162005
  • Sub Project Total Cost
  • ARRA Funded
  • CFDA Code
    837
  • Ed Inst. Type
  • Funding ICs
    NHLBI:162005\
  • Funding Mechanism
  • Study Section
    ZRG1
  • Study Section Name
    Special Emphasis Panel
  • Organization Name
    COLLAGEN MATRIX, INC.
  • Organization Department
  • Organization DUNS
  • Organization City
    FRANKLIN LAKES
  • Organization State
    NJ
  • Organization Country
    UNITED STATES
  • Organization Zip Code
    07417
  • Organization District
    UNITED STATES